Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,975 | 5,986 | 3,253 | 2,409 | 4,338 |
| Operating Income | -4,975 | -5,986 | -3,253 | -2,409 | -4,338 |
| Interest Expense | 6 | 3 | 2 | 4 | 6 |
| Other Income | 44 | 33 | 37 | 39 | 43 |
| Pre-tax Income | -4,937 | -5,956 | -3,219 | -2,375 | -4,301 |
| Net Income Continuous | -4,937 | -5,956 | -3,219 | -2,375 | -4,301 |
| Net Income | $-4,937 | $-5,956 | $-3,219 | $-2,375 | $-4,301 |
| EPS Basic Total Ops | -7.30 | -4.64 | -5.76 | -6.42 | -18.93 |
| EPS Basic Continuous Ops | -7.30 | -4.66 | -5.76 | -6.42 | -18.95 |
| EPS Diluted Total Ops | -7.30 | -4.64 | -5.76 | -6.42 | -18.93 |
| EPS Diluted Continuous Ops | -7.30 | -4.66 | -5.76 | -6.42 | -18.95 |
| EPS Diluted Before Non-Recurring Items | N/A | -10.15 | -5.76 | -6.42 | -18.97 |
| EBITDA(a) | $-4,973 | $-5,985 | $-3,253 | $-2,408 | $-4,337 |